Recurrent Atypical Chronic Myeloid Leukemia
Oncology·MeSH: Myelodysplastic-Myeloproliferative Diseases
Prevalence
12.0 / 100K
Incidence
1.9 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Recurrent Atypical Chronic Myeloid Leukemia?
There are 1 clinical trial targeting Recurrent Atypical Chronic Myeloid Leukemia tracked by BioSniper.
What is the prevalence of Recurrent Atypical Chronic Myeloid Leukemia?
The estimated prevalence of Recurrent Atypical Chronic Myeloid Leukemia is approximately 12.0 per 100,000 population.
Deep-dive into Recurrent Atypical Chronic Myeloid Leukemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis